Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte merck.ca .Actuellement, hébergé dans United States et son fournisseur de services est Merck and Co. Inc. .
Latitude:
40.557357788086
Longitude:
-74.285545349121
Pays:
United States (us)
Ville:
Rahway
Région:
New Jersey
ISP:
Merck and Co. Inc.
the related websites
domaine
Titre
canada-services.com etudier au canada, travailler au canada, immigrer au canada, canada, canada-serv forum-logement-etudiant.fr canada goos pas chere-canada goose modele victoria,acheter canada goose paris,di marsetvenusspa.fr doudoune canada goose,canada goose prix,canada goose pas cher,canada goose chill gitedufortrocher.fr doudoune canada goose,canada goose solde,achat canada goose homme parka en franc villasdugardon.fr gute qualität canada goose,canada goose schweiz,canada goose outlet günstig prod babyroi.fr canada goose pas cher,prix doudoune canada goose,veste canada goose homme pas ch anenemy.fr canada goose pas cher,canada goose solde,canada goose femme pas cher,canada goos lsbf.fr canada goose pas cher,parka canada goose homme pas cher,doudoune femme canada go leasecosts.ca leasecosts canada | best canada prices for suv, compact, luxury, coupe & mini-va tuac.ca accueil - tuac canada - le principal syndicat du secteur privé au canada armycadetleague.ca army cadet league of canada | la ligue des cadets de l’armée du canada – the arm aventure-voyages.com location de motorhomes au canada, cours d'anglais au canada, voile en patagonie, assep.ca hébergement web canada: compte suspendu | web hosting canada: account suspended lekagibi.fr doudoune canada goose femme,homme & enfant soldes france en ligne | veste canada electronic-visa.org evisa canada - formulaire demande ave canada - electronic-visa.org
Analyse d'en-tête HTTP
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.4.7 (Ubuntu) contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
Content-Length: 14009 X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Content-Encoding: gzip Set-Cookie: oam.Flash.RENDERMAP.TOKEN=-k4g0vzwbj; Path=/foundation Expires: Tue, 31 Jul 2018 17:45:25 GMT Vary: Host,Accept-Encoding Server: Apache/2.4.7 (Ubuntu) Connection: keep-alive Pragma: no-cache Cache-Control: private, no-cache, no-store, must-revalidate Date: Tue, 31 Jul 2018 17:45:25 GMT X-Frame-Options: SAMEORIGIN Content-Type: text/html;charset=UTF-8
DNS
soa: ns-466.awsdns-58.com. awsdns-hostmaster.amazon.com. 1 7200 900 1209600 86400 txt: "spf2.0/pra ip4:81.91.104.0/24 include:cust-senderid.exacttarget.com -all" ns: ns-1192.awsdns-21.org. ipv4: IP:155.91.26.4 7054 MERCK - Merck and Co., Inc., US US mx: MX preference = 0, mail exchanger = marvin.merck.com.
HtmlToText
<iframe src="https://www.googletagmanager.com/ns.html?id=gtm-m49qw5n" height="0" width="0" style="display:none;visibility:hidden"/> menu menu worldwide contact us english français about us close about us corporate responsibility contributions and donations how we operate leadership our history featured stories research close research our research process pipeline clinical trials invent with us products close vaccines prescription products animal health newsroom close latest news company statement corporate news product news research and development news social media careers close careers why merck? apply now english français about us navigate_next corporate responsibility how we operate leadership our history featured stories research navigate_next research our research process pipeline clinical trials invent with us product navigate_next vaccines prescription products animal health newsroom navigate_next latest news company statements corporate news product news research and development news social media careers navigate_next careers apply now why merck? contact us cookies we have always been and always will be inventing, and we do it for the single greatest purpose: life. learn more the merck patients first award recognizes excellence and innovation in patient-centred care learn more check out our latest news learn more voluntary disclosure of payments to healthcare professionals and healthcare organizations learn more latest news connect with us on social other merck sites real-world study of zepatier ® (elbasvir and grazoprevir) demondtrates high rates of sustained virologic response in a broad range of patients with chronic hepatitis c infection across canada april 12, 2018 major funding expected in support of alberta's life sciences' sector june 20, 2017 indigenous researchers receive $2.6 million funding from merck canada inc. for indigenous maternal and child health program in ontario may 25, 2017 recent floods: alert for merck canada inc. employees may 8, 2017 merck applauds world health organization’s (who) world immunization week april 21, 2017 see all latest news other merck sites merck patients first awards merck for mothers merck manuals merck.com investors copyright © 2018 merck canada inc. all rights reserved. privacy terms of use merck sharp & dohme corp., a subsidiary of merck & co., inc. social media guidelines terms and conditions for sales you are now leaving the merck.ca site, a website maintained by merck canada inc. the link is provided for your convenience only. merck canada inc. takes no responsibility for the content of any website maintained by any third party and makes no representation as to the accuracy or completeness of any information available through this or any subsequent link. ok cancel forward-looking statement × forward-looking statement of msd & co., inc., kenilworth, nj, usa this website of msd & co., inc., kenilworth, nj, usa (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the united states private securities litigation reform act of 1995. these statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. if underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. the company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 annual report on form 10-k and the company’s other filings with the securities and exchange commission (sec) available at the sec’s internet site (www.sec.gov). no duty to update the information contained in this website was current as of the date presented. the company assumes no duty to update the information to reflect subsequent developments. consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
Top search words for merck.ca ampampampltiframe , width="0" , height="0" , menu , worldwide , contact , id=gtm-m49qw5n" , english ,
Analyse PopURL pour merck.ca
http://www.merck.ca/en/home/en/newsroom/product-news/
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain name: merck.caREGISTRAR CIRAREFERRER http://www.cira.ca/SERVERS SERVER ca.whois-servers.netARGS merck.caPORT 43TYPE domainRegrInfo DOMAIN STATUS registeredCREATED 2002-02-13EXPIRES 2018-02-13CHANGED 2016-01-12SPONSOR MarkMonitor International Canada Ltd.NSERVER CBRU.BR.NS.ELS-GMS.ATT.NET 68.94.156.132CMTU.MT.NS.ELS-GMS.ATT.NET 99.99.99.132NS9.CUSTOMER.LEVEL3.NET 209.244.4.148NS6.CUSTOMER.LEVEL3.NET 209.244.4.85NAME merck.caOWNER NAME Merck Canada Inc.ADMIN NAME Benjamin AndersonADDRESS PHONE +1.2673055276FAX +1.9082593966EMAIL merckdomains@merck.comTECH NAME Benjamin AndersonADDRESS PHONE +1.2673055276FAX +1.9082593966EMAIL merckdomains@merck.comREGISTERED yes
Go to top
merck.ca rapport :
Visitez le site
